Skip to main content

Table 4 Association between UGT2B15, UGT2B17, UGT2B28 H-scores and pathological Gleason score

From: UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression

  Pathological Gleason Score  
  2 – 6 3 + 4 (4 + 3) – 10 P-value
UGT2B15     0.55*
 Median 42.8 39.0 31.3  
 Q1-Q3 28.8-61.9 21.5-65.9 24.5-50.5  
  < Median 16 (41%) 48 (48%) 31 (61%) 0.15**
  ≥ Median 23 (59%) 52 (52%) 20 (39%)  
UGT2B17     0.84*
 Median 72.4 78.5 78.2  
 Q1-Q3 59.8-88.1 58.6-94.9 68.2-84.6  
  < Median 22 (56%) 48 (48%) 25 (49%) 0.66**
  ≥ Median 17 (44%) 52 (52%) 26 (51%)  
UGT2B28     0.89*
 Median 86.0 86.0 86.4  
 Q1-Q3 58.4-102.9 63.6-109.3 74.1-102.2  
  < Median 20 (51%) 50 (50%) 25 (49%) 0.98**
  ≥ Median 19 (49%) 50 (50%) 26 (51%)  
  1. P-value calculated using *Kruskal-Wallis test or **chi-squared test